Litigation
Nov. 6, 2014
Court allows hedge fund to vote at Allergan board meeting
A federal judge Tuesday ruled that hedge fund Pershing Square Capital Management would not be barred from voting its majority stake in a long-running hostile takeover bid for Botox-maker Allergan Inc.
Daily Journal Staff Writer
SANTA ANA - A federal judge Tuesday ruled that hedge fund Pershing Square Capital Management would not be barred from voting its majority stake in a long-running hostile takeover bid for Botox-maker Allergan Inc.
The decision by U.S. District Judge David O. Carter of the Central District could force Allergan to sell to Valeant Pharmaceuticals International, which partnered with Pershing Squar...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$895, but save $100 when you subscribe today… Just $795 for the first year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In